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quinolones appear to be a promising agent on the basis of in 
liit~o results. Anaissie et al. reported that imipenem, ceftazi- 
dime and ciprofloxacin are effective against P. putida (6). It 
has also been reported that meropenem shows a good to 
moderate activity against P. putida (9). 
Stockley et al. reported that nebulized amoxicillin is 
effective to control chronic purulent bronchiectasis (10). As 
this patient experienced recurrent pneumonia, nebulization 
of antibiotics may be useful to prevent pneumonia. 
The case described here emphasizes that a mucoid 
strain of P. putida can be isolated from human clinical 
sources, and may cause pulmonary infection in an 
immunocompetent host. 
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Introduction Case 1 
In cystic fibrosis, (CF) the lungs are usually affected dif- 
fusely, but in some patients, focal disease may predominate 
(1). Aggressive medical therapy with intravenous antibiotics 
and chest physiotherapy is the first-line treatment, but in 
cases which fail to respond, surgical resection of the affected 
lobe has been advocated (2). We reviewed the clinical 
courses, up to 15 months post-operatively, of all three of 
our patients in whom this procedure had been undertaken. 
All patients had received prolonged intensive medical treat- 
ment without significant improvement in their clinical or 
radiological status prior to surgery. 
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A lo-year-old boy had persistent right upper lobe bron- 
chiectasis. His mean lung function tests (o/ predicted 
for height) preceding lobectomy, derived from all lung 
function results recorded over the year, were FEV, 
44% (SD 3.7%) and FVC 61% (SD 9.0%), and he required 
seven hospital admissions. During the post-operative 
year, his mean lung function tests improved, with FEV, 
48% (SD 6.4%) and FVC 68% (SD 9.6%): and he was 
admitted five times for treatment. One year post- 
operatively, his weight centile position was unchanged but 
his height centile position had improved; although he 
remained pre-pubertal. His chest X-ray Crispin Norman 
(CN) score had fallen from 28, pre-operatively, to 8 
(Plate 1). 
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PLATE 1. PA chest radiographs of Case 1 showing air-filled bronchi within the collapsed right upper lobe pre-operatively 
(a), and appearances following right upper lobectomy and insertion of a totally implantable venous access device (b). 
Case 2 
Another lo-year-old boy had suffered from left lower lobe 
collapse for 2 years. Overall, mean lung function during the 
post-operative year was reduced, with FEV, 32% (SD 5.5%) 
and FVC 42% (SD 4.8%) compared to 50% (SD 0.0%) and 
60% (SD 4.2%), respectively, during the pre-operative year. 
However the trend in lung function following recovery from 
surgery showed gains in FEV, of +5% and FVC of + 10% 
(percentages predicted for height) between 3 and 15 months 
post-operatively. He was admitted four times in the pre- 
operative year and the same number of times in the 
post-operative year, although this was on a new programme 
of elective 3-monthly antibiotic courses. One year after 
operation, his weight centile had declined slightly although 
his height centile was unchanged. His CN score had fallen 
from 8 to 5. 
Case 3 
This 7-year-old girl had right lower lobe bronchiectasis. 
Mean lung function results in the pre-operative year were 
FEV, 76% (SD 6.5%) and FVC 77% (SD 6.5%) which fell to 
53% (SD 10.8%) and 57% (SD 14.10/o), respectively, in the 
year following her lobectomy. As in Case 2, however, she 
showed a trend of improving lung function between 3 and 
15 months post-operatively, with gains in FEV, and FVC 
of +6 and +24% (percentages predicted for height), 
respectively. She required only two admissions in the post- 
operative year compared to five admissions pre-operatively. 
Height centile improved although weight centile fell. 
Her CN score rose from 11 at the time of operation to 16 
1 year later. 
Discussion 
Other centres have reported their experience with CF 
patients treated by pulmonary resection (l-5). The 
observed benefits have been a reduction in symptoms of 
cough and sputum production, less frequent infective 
exacerbations and reduced rates of hospital admission (as 
seen in the study patients). Marmon et al. (2) observed little 
change in their 11 patients’ lung function post-operatively, 
Smith et al. (3) noted significant decreases in post-operative 
FEVi but not FVC in their 14 patients, and Lucas et al. (4) 
reported both increased and decreased respiratory function 
among six patients. Two of our patients experienced reduc- 
tion in mean pulmonary function post-operatively, but one 
improved. Interestingly, once the patients had recovered 
from surgery (3 months post-operatively), all three showed 
increases in FEV, and FVC over the subsequent 12 months, 
perhaps indicating that the removal of the nidus of infec- 
tion had allowed a degree of overall lung recovery. Growth 
was not always commented upon in other series. Mearns 
et al. (1) observed both increases and decreases in growth 
centile position post-operatively, as was the case in our 
patients, whereas Steinkampand et al. (5) recorded 
improvement in weight centile in all three of their subjects 
(height centiles not recorded). Reduction in CN score, as 
occurred in two of our patients, is perhaps not surprising 
since the areas of lung with the most severe disease had 
been removed. 
The small number of patients in this review precludes any 
definitive conclusions about the value of lobectomy in CF. 
However, all three patients had some evidence of benefit 
from the procedure, particularly Case 1 who improved in 
almost all parameters examined. Lobectomy may be a 
useful treatment option for those CF patients in whom 
vigorous medical therapy for localized pulmonary disease 
has failed. 
Note 
Previous thoracic surgery may make subsequent heart-lung 
transplantation more difficult. However, since heart-lung 
transplantation began in the U.K. in 1985, the relative and 
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absolute contraindications have changed. Previous lung 
resection is no longer an absolute contraindication, and 
patients treated by lobectomy have successfully undergone 
subsequent transplantation. Each patient should be 
assessed individually. 
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Introduction 
Sarcoidosis is a multisystem granulomatous disorder of 
unknown aetiology. The respiratory system is most com- 
monly involved and therefore the majority of cases come 
under the care of respiratory physicians. Symptomatic 
cardiac involvement is found in less than 5% of patients (1); 
although cardiac granulomata have been noted in as many 
as 27% at autopsy (2). The diagnosis of cardiac sarcoidosis 
can be difficult and in established cases the prognosis is 
poor (3). Corticosteroids reportedly help and are commonly 
used, although patients are still prone to sudden death and 
progression to end-stage cardiomyopathy (4). We report a 
case of cardiac sarcoid diagnosed using magnetic resonance 
imaging (MRI) which suggests that this form of imaging 
can lead to an early diagnosis at which stage treatment may 
be more likely to be beneficial. 
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Case Report 
A 55-year-old factory foreman initially presented following 
an episode of syncope and two episodes of near syncope. 
These episodes were all of short duration, occurred over a 
period of 6 months and were not associated with palpita- 
tions or chest pain. Clinical examination was completely 
normal, blood pressure was 130/80, breath sounds were 
vesicular and heart sounds were normal. He was an 
ex-smoker who had been previously well but did describe 
the occurrence of red blotches on his lower legs 18 months 
earlier, which had been self-limiting. 
Electrocardiography showed sinus rhythm with a QRS 
axis of+45 degrees. Twenty-four hour Holter monitoring 
showed sinus rhythm with an occasional dropped beat. His 
chest X-ray revealed bilateral hilar lymphadenopathy, 
raising the possibility of sarcoidosis. Spirometry was supra- 
normal. HRCT of the thorax revealed huge paratracheal, 
subcarinal and parabronchial lymphadenopathy but no 
evidence of interstitial lung involvement. Fibre-optic bron- 
choscopy revealed a small nodule in the apical segment of 
the right lower lobe, biopsy of which showed noncaseating 
